Search Results 71-80 of 15196 for infliximab

  1. Adult Still disease - Diagnosis and treatment - Mayo Clinic

    Other biologics that may be helpful for treating adult Still disease include etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira) and rituximab ( ...

  2. Ustekinumab-srlf (intravenous route, subcutaneous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Poliovirus Vaccine, Live; Rotavirus Vaccine, Live; Rubella ...

  3. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Prior use of any TNFα antagonist including (but not limited to) infliximab, adalimumab, golimumab, certolizumab, or biosimilar agents at any time. Prior or ...

  4. Ustekinumab-stba (intravenous route, subcutaneous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Poliovirus Vaccine, Live; Rotavirus Vaccine, Live; Rubella ...

  5. Adalimumab-ryvk (subcutaneous route) - Mayo Clinic

    Adalimumab-ryvk injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis. It is used in children 2 years ...

  6. Smallpox and mpox vaccine, live (intradermal route, subcutaneous route) - Mayo Clinic

    Infliximab; Ixekizumab; Lebrikizumab-lbkz; Leflunomide; Leniolisib; Lovotibeglogene Autotemcel; Mirikizumab-mrkz; Mycophenolate Mofetil; Mycophenolic Acid ...

  7. Program to Evaluate Tulisokibart for Moderate to Severe Crohn’s Disease - Mayo Clinic

    At least one 6-week induction regimen of infliximab (≥ 5 mg/kg IV at Weeks 0, 2, and 6), OR; At least one 4-week induction regimen of adalimumab (one 160-mg ...

  8. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission - Mayo Clinic

    ... Infliximab 10 mg/kg q4wk > 5mg/ml Adalimumab 40 mg qwk > 7.5mg/ml Certolizumab 400 mg q2wk > 25mg/ml Vedolizumab 300 mg q4wk >15mg/mlUstekinumab 90 mg q4wk ...

  9. Ustekinumab-kfce (intravenous route, subcutaneous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Poliovirus Vaccine, Live; Rotavirus Vaccine, Live; Rubella ...

  10. Vedolizumab (intravenous route, subcutaneous route) - Mayo Clinic

    Infliximab; Natalizumab. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since ...